← Back to Search

Behavioral Intervention

MORE+JITAI for Chronic Pain (MORE-JITAI Trial)

N/A
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 1-month follow-up
Awards & highlights

MORE-JITAI Trial Summary

This trial studies how tech-based mindfulness may help people with chronic pain taking opioids in the long-term.

Eligible Conditions
  • Chronic Pain

MORE-JITAI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 1-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 1-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in momentary craving
Change in momentary pain: numeric rating scale
Secondary outcome measures
Heart rate
Change in momentary positive affect
Change in momentary stress
Other outcome measures
Change in chronic pain symptoms
Change in mindful reinterpretation of pain sensations
Change in opioid dose
+2 more

MORE-JITAI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Oriented Recovery Enhancement+JITAIExperimental Treatment1 Intervention
Participants will attend a telehealth Mindfulness-Oriented Recovery Enhancement (MORE) group plus mindfulness JITAI weekly for eight weeks.
Group II: Supportive PsychotherapyActive Control1 Intervention
Participants will attend a telehealth supportive psychotherapy group weekly for eight weeks.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,102 Previous Clinical Trials
1,779,198 Total Patients Enrolled
28 Trials studying Chronic Pain
4,770 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby May 2025